These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24356898)

  • 1. Chaperone therapy for GM2 gangliosidosis: effects of pyrimethamine on β-hexosaminidase activity in Sandhoff fibroblasts.
    Chiricozzi E; Niemir N; Aureli M; Magini A; Loberto N; Prinetti A; Bassi R; Polchi A; Emiliani C; Caillaud C; Sonnino S
    Mol Neurobiol; 2014 Aug; 50(1):159-67. PubMed ID: 24356898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open-label Phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay-Sachs or Sandhoff variants).
    Clarke JT; Mahuran DJ; Sathe S; Kolodny EH; Rigat BA; Raiman JA; Tropak MB
    Mol Genet Metab; 2011 Jan; 102(1):6-12. PubMed ID: 20926324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrimethamine as a potential pharmacological chaperone for late-onset forms of GM2 gangliosidosis.
    Maegawa GH; Tropak M; Buttner J; Stockley T; Kok F; Clarke JT; Mahuran DJ
    J Biol Chem; 2007 Mar; 282(12):9150-61. PubMed ID: 17237499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of recombinant beta-hexosaminidase A, a potential enzyme for replacement therapy for Tay-Sachs and Sandhoff diseases, in the methylotrophic yeast Ogataea minuta.
    Akeboshi H; Chiba Y; Kasahara Y; Takashiba M; Takaoka Y; Ohsawa M; Tajima Y; Kawashima I; Tsuji D; Itoh K; Sakuraba H; Jigami Y
    Appl Environ Microbiol; 2007 Aug; 73(15):4805-12. PubMed ID: 17557860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological enhancement of beta-hexosaminidase activity in fibroblasts from adult Tay-Sachs and Sandhoff Patients.
    Tropak MB; Reid SP; Guiral M; Withers SG; Mahuran D
    J Biol Chem; 2004 Apr; 279(14):13478-87. PubMed ID: 14724290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bicistronic lentiviral vector corrects beta-hexosaminidase deficiency in transduced and cross-corrected human Sandhoff fibroblasts.
    Arfi A; Bourgoin C; Basso L; Emiliani C; Tancini B; Chigorno V; Li YT; Orlacchio A; Poenaru L; Sonnino S; Caillaud C
    Neurobiol Dis; 2005 Nov; 20(2):583-93. PubMed ID: 15953731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-Arginine Ameliorates Defective Autophagy in GM2 Gangliosidoses by mTOR Modulation.
    Castejón-Vega B; Rubio A; Pérez-Pulido AJ; Quiles JL; Lane JD; Fernández-Domínguez B; Cachón-González MB; Martín-Ruiz C; Sanz A; Cox TM; Alcocer-Gómez E; Cordero MD
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly phosphomannosylated enzyme replacement therapy for GM2 gangliosidosis.
    Tsuji D; Akeboshi H; Matsuoka K; Yasuoka H; Miyasaki E; Kasahara Y; Kawashima I; Chiba Y; Jigami Y; Taki T; Sakuraba H; Itoh K
    Ann Neurol; 2011 Apr; 69(4):691-701. PubMed ID: 21520232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular heterogeneity in the infantile and juvenile forms of Sandhoff disease (O-variant GM2 gangliosidosis).
    O'Dowd BF; Klavins MH; Willard HF; Gravel R; Lowden JA; Mahuran DJ
    J Biol Chem; 1986 Sep; 261(27):12680-5. PubMed ID: 3017984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inefficiency in GM2 ganglioside elimination by human lysosomal beta-hexosaminidase beta-subunit gene transfer to fibroblastic cell line derived from Sandhoff disease model mice.
    Itakura T; Kuroki A; Ishibashi Y; Tsuji D; Kawashita E; Higashine Y; Sakuraba H; Yamanaka S; Itoh K
    Biol Pharm Bull; 2006 Aug; 29(8):1564-9. PubMed ID: 16880605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GM2 gangliosidoses in Spain: analysis of the HEXA and HEXB genes in 34 Tay-Sachs and 14 Sandhoff patients.
    Gort L; de Olano N; Macías-Vidal J; Coll MA;
    Gene; 2012 Sep; 506(1):25-30. PubMed ID: 22789865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin.
    Jeyakumar M; Butters TD; Cortina-Borja M; Hunnam V; Proia RL; Perry VH; Dwek RA; Platt FM
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6388-93. PubMed ID: 10339597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effects of stem cells and substrate reduction in juvenile Sandhoff mice.
    Arthur JR; Lee JP; Snyder EY; Seyfried TN
    Neurochem Res; 2012 Jun; 37(6):1335-43. PubMed ID: 22367451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversion of the biochemical defects in murine embryonic Sandhoff neurons using a bicistronic lentiviral vector encoding hexosaminidase alpha and beta.
    Arfi A; Zisling R; Richard E; Batista L; Poenaru L; Futerman AH; Caillaud C
    J Neurochem; 2006 Mar; 96(6):1572-9. PubMed ID: 16441513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canine GM2-Gangliosidosis Sandhoff Disease Associated with a 3-Base Pair Deletion in the HEXB Gene.
    Wang P; Henthorn PS; Galban E; Lin G; Takedai T; Casal M
    J Vet Intern Med; 2018 Jan; 32(1):340-347. PubMed ID: 29106755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular pathogenesis and therapeutic approach of GM2 gangliosidosis].
    Tsuji D
    Yakugaku Zasshi; 2013; 133(2):269-74. PubMed ID: 23370522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate Reduction Therapy for Sandhoff Disease through Inhibition of Glucosylceramide Synthase Activity.
    Marshall J; Nietupski JB; Park H; Cao J; Bangari DS; Silvescu C; Wilper T; Randall K; Tietz D; Wang B; Ying X; Leonard JP; Cheng SH
    Mol Ther; 2019 Aug; 27(8):1495-1506. PubMed ID: 31208914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic Gene Transfer of a Hexosaminidase Variant Using an scAAV9.47 Vector Corrects GM2 Gangliosidosis in Sandhoff Mice.
    Osmon KJ; Woodley E; Thompson P; Ong K; Karumuthil-Melethil S; Keimel JG; Mark BL; Mahuran D; Gray SJ; Walia JS
    Hum Gene Ther; 2016 Jul; 27(7):497-508. PubMed ID: 27199088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced secretion of beta-hexosaminidase by human brain endothelial cells: a novel approach in Sandhoff disease?
    Batista L; Miller F; Clave C; Arfi A; Douillard-Guilloux G; Couraud PO; Caillaud C
    Neurobiol Dis; 2010 Mar; 37(3):656-60. PubMed ID: 20005954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis.
    Sango K; McDonald MP; Crawley JN; Mack ML; Tifft CJ; Skop E; Starr CM; Hoffmann A; Sandhoff K; Suzuki K; Proia RL
    Nat Genet; 1996 Nov; 14(3):348-52. PubMed ID: 8896570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.